ELOVL2 (ELOVL fatty acid elongase 2)

2017-08-01  

Identity

HGNC
LOCATION
6p24.2
LOCUSID
ALIAS
SSC2
FUSION GENES

Other Information

Locus ID:

NCBI: 54898
MIM: 611814
HGNC: 14416
Ensembl: ENSG00000197977

Variants:

dbSNP: 54898
ClinVar: 54898
TCGA: ENSG00000197977
COSMIC: ELOVL2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000197977ENST00000354666Q9NXB9
ENSG00000197977ENST00000354666A0A024QZV3

Expression (GTEx)

0
5
10
15
20
25
30

Pathways

PathwaySourceExternal ID
Fatty acid elongationKEGGko00062
Biosynthesis of unsaturated fatty acidsKEGGko01040
Fatty acid elongationKEGGhsa00062
Biosynthesis of unsaturated fatty acidsKEGGhsa01040
Fatty acid biosynthesis, elongation, endoplasmic reticulumKEGGhsa_M00415
Fatty acid biosynthesis, elongation, endoplasmic reticulumKEGGM00415
Fatty acid metabolismKEGGhsa01212
Fatty acid metabolismKEGGko01212
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Fatty acid, triacylglycerol, and ketone body metabolismREACTOMER-HSA-535734
Triglyceride BiosynthesisREACTOMER-HSA-75109
Fatty Acyl-CoA BiosynthesisREACTOMER-HSA-75105
Synthesis of very long-chain fatty acyl-CoAsREACTOMER-HSA-75876
alpha-linolenic (omega3) and linoleic (omega6) acid metabolismREACTOMER-HSA-2046104
alpha-linolenic acid (ALA) metabolismREACTOMER-HSA-2046106
Linoleic acid (LA) metabolismREACTOMER-HSA-2046105

References

Pubmed IDYearTitleCitations
367685762023An ELOVL2-Based Epigenetic Clock for Forensic Age Prediction: A Systematic Review.1
374932522023ELOVL2-methylation and renal and cardiovascular event in patients with chronic kidney disease.0
367685762023An ELOVL2-Based Epigenetic Clock for Forensic Age Prediction: A Systematic Review.1
374932522023ELOVL2-methylation and renal and cardiovascular event in patients with chronic kidney disease.0
348414372022ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.11
356408212022ELOVL2 restrains cell proliferation, migration, and invasion of prostate cancer via regulation of the tumor suppressor INPP4B.4
348414372022ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.11
356408212022ELOVL2 restrains cell proliferation, migration, and invasion of prostate cancer via regulation of the tumor suppressor INPP4B.4
328437132021Influence of genetic variants in FADS2 and ELOVL2 genes on BMI and PUFAs homeostasis in children and adolescents with obesity.10
331742552021Higher Increase in Plasma DHA in Females Compared to Males Following EPA Supplementation May Be Influenced by a Polymorphism in ELOVL2: An Exploratory Study.6
328437132021Influence of genetic variants in FADS2 and ELOVL2 genes on BMI and PUFAs homeostasis in children and adolescents with obesity.10
331742552021Higher Increase in Plasma DHA in Females Compared to Males Following EPA Supplementation May Be Influenced by a Polymorphism in ELOVL2: An Exploratory Study.6
325027622020FADS1 and ELOVL2 polymorphisms reveal associations for differences in lipid metabolism in a cross-sectional population-based survey of Brazilian men and women.5
325846102020Association Between Genetic Variants in FADS1-FADS2 and ELOVL2 and Obesity, Lipid Traits, and Fatty Acids in Tunisian Population.10
326822822020Genetic variants in FADS1 and ELOVL2 increase level of arachidonic acid and the risk of Alzheimer's disease in the Tunisian population.19

Citation

Dessen P

ELOVL2 (ELOVL fatty acid elongase 2)

Atlas Genet Cytogenet Oncol Haematol. 2017-08-01

Online version: http://atlasgeneticsoncology.org/gene/57022/css/lib/js/lib/css/lib/bootstrap.min.css